Pages

Tuesday, January 17, 2017

FDA issues final 503A compounding guidance prohibiting office use ...

www.pharmacist.com/.../fda-issues-final-503a-compounding-guidance-prohibiting-of...
20 mins ago - At the end of 2016, FDA issued final guidance that will require pharmacists to obtain a valid “patient-specific prescription” for each drug compounded under ...